Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole in Unverricht-Lundborg Disease
NCT00639119Phase 2Unknown
- Sponsor
- University of Turku
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropinirole in Unverricht-Lundborg disease (ULD), sponsored by University of Turku. Status: unknown.
02
Drugs
ropinirole
03
Conditions
Unverricht-Lundborg disease (ULD)
Beyond the preview
Go deeper on NCT00639119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00639119.